Tysabri Touch Form Pdf. Web tysabri is an integrin receptor antagonist indicated for treatment of: Verify that the patient is currently authorized to receive tysabri prior to each infusion provide the patient with a copy of the patient medication guide prior to each infusion
Receiving Your TYSABRI® (natalizumab) Infusion
Tysabri is a prescription medicine used to treat adults with: Web •have you sign the touch® patient enrollment form what is tysabri? Tysabri increases the risk of pml. If diagnosis of relapsing forms of multiple sclerosis (ms). Web our records indicate that ’s authorization to receive tysabri will expire on and he/she will no longer be able to receive tysabri. This is to make sure that you are informed about the risks of treatment with tysabri, including the risk of progressive multifocal leukoencephalopathy (pml). Although you have been receiving tysabri for 2 years, it is important that you are reminded that the risk of pml increases beyond this time. Maintain compliance with the touch prescribing program. Web current as of 6/1/2013. Web tysabri increases your risk of getting a rare brain infection—called progressive multifocal leukoencephalopathy (pml)—that most leads to death instead severe disability.
Web when your doctor writes you a prescription for tysabri, both of you will review, complete, and sign the enrollment form for the touch prescribing program. Tysabri increases the risk of pml Reduce administrative burden/paperwork for prescribers and infusion sites. Web tysabri increases your risk of getting a rare brain infection—called progressive multifocal leukoencephalopathy (pml)—that most leads to death instead severe disability. Streamline communication to/from prescribers and infusion sites. Web •have you sign the touch® patient enrollment form what is tysabri? Verify that the patient is currently authorized to receive tysabri prior to each infusion provide the patient with a copy of the patient medication guide prior to each infusion Web tysabri treatment continuation form tysabri (natalizumab) 300 mg concentrate solution for infusion this form should be read carefully before continuing tysabri treatment for more than 2 years. If diagnosis of relapsing forms of multiple sclerosis (ms). Unified commitment to health phone: Tysabri is a prescription medicine used to treat adults with:
